3-(5-(4-acryloylpiperazin-1-yl)-2-(trifluoromethyl)phenyl)-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1H-pyrrole-2,5-dione

ID: ALA4522075

PubChem CID: 155542904

Max Phase: Preclinical

Molecular Formula: C25H20F3N5O3

Molecular Weight: 495.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ncccc45)C(=O)NC3=O)c2)CC1

Standard InChI:  InChI=1S/C25H20F3N5O3/c1-2-19(34)33-10-8-32(9-11-33)14-5-6-18(25(26,27)28)16(12-14)20-21(24(36)31-23(20)35)17-13-30-22-15(17)4-3-7-29-22/h2-7,12-13H,1,8-11H2,(H,29,30)(H,31,35,36)

Standard InChI Key:  TZJNLXQOAICYQK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   15.4977  -13.4465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3149  -13.4465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5693  -12.6698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9063  -12.1877    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2476  -12.6698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4703  -12.4177    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.3468  -12.4184    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7961  -14.1078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5427  -14.8847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2033  -15.3658    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6133  -14.1088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8639  -14.8854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6601  -15.0553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2066  -14.4495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9512  -13.6712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1556  -13.5050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0171  -14.1040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2035  -14.0161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7225  -14.6758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0538  -15.4237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8709  -15.5080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3483  -14.8474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7648  -13.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3652  -12.6943    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.0331  -12.5106    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.9166  -13.2220    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.2053  -16.2530    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7273  -16.9106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0584  -17.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8706  -17.7403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3507  -17.0786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0186  -16.3299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2023  -18.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7215  -19.1478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0150  -18.5732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3468  -19.3200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  5  6  2  0
  3  7  2  0
  8  9  2  0
  9 10  1  0
 10 12  1  0
 11  8  1  0
  2  8  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  1 17  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
 18 23  1  0
 21 27  1  0
 27 28  1  0
 27 32  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4522075

    ---

Associated Targets(Human)

JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 495.46Molecular Weight (Monoisotopic): 495.1518AlogP: 2.98#Rotatable Bonds: 4
Polar Surface Area: 98.40Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.87CX Basic pKa: 3.18CX LogP: 2.77CX LogD: 2.76
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.43Np Likeness Score: -0.71

References

1. Shi L, Zhong Z, Li X, Zhou Y, Pan Z..  (2019)  Discovery of an Orally Available Janus Kinase 3 Selective Covalent Inhibitor.,  62  (2): [PMID:30615446] [10.1021/acs.jmedchem.8b01823]

Source